Latest data on gross domestic spending on R&D, which is defined as the total expenditure (current and capital) on R&D carried out by all resident companies, research institutes, university and government laboratories, etc., in a country.
OECD countries are developing strategies to improve the quality of life of those affected by dementia. Sharing and linking population-based health and health care data with detailed clinical and biological data to create an international resource could be one of these strategies.
Dementia is a devastating condition. The OECD looks at ways to harness information technologies and big data to improve the prevention and treatment of the disease; and examines the innovation model to mobilise the research and tools needed to address it.
Science advice plays an increasing role in the formulation of policy. Governments require scientific evidence from long-term policy development through to urgent crisis management.
The use of new nanomaterials in tyre production could help foster the sustainability of the tyre industry and reduce the environmental impact of vehicles, if the potential environmental, health and safety risks of the technology are managed carefully.
Synthetic biology is a powerful and transformative technique which merges biology and engineering. It opens up enormous scientific, commercial, and health opportunities.
Work in the area of genetics and genomics undertaken by the OECD including guidelines, events and reports.